advertisement
Zhang Q 28
Showing records 1 to 25 | Display all abstracts from Zhang Q104691 Trends in the prevalence of vision impairment among the oldest-old Chinese population from 1998 to 2018
Luo Y
Journal of global health 2022; 12: 11006
104628 Five-year incidence of primary glaucoma and related risk factors - The Handan eye study
Zhang Y
Acta Ophthalmologica 2023; 101: e50-e60
104938 Genetic and clinical features of BEST1-associated retinopathy based on 59 Chinese families and database comparisons
Wang Y
Experimental Eye Research 2022; 223: 109217
105049 Covalent Organic Framework (COF): A Drug and Carrier to Attenuate Retinal Ganglion Cells Death in an Acute Glaucoma Mouse Model
Yao K; Liang X
Polymers 2022; 14:
104691 Trends in the prevalence of vision impairment among the oldest-old Chinese population from 1998 to 2018
Zhang Q
Journal of global health 2022; 12: 11006
104628 Five-year incidence of primary glaucoma and related risk factors - The Handan eye study
Hao J
Acta Ophthalmologica 2023; 101: e50-e60
104938 Genetic and clinical features of BEST1-associated retinopathy based on 59 Chinese families and database comparisons
Jiang Y; Li X
Experimental Eye Research 2022; 223: 109217
104691 Trends in the prevalence of vision impairment among the oldest-old Chinese population from 1998 to 2018
Han L
Journal of global health 2022; 12: 11006
104628 Five-year incidence of primary glaucoma and related risk factors - The Handan eye study
Zhang Q
Acta Ophthalmologica 2023; 101: e50-e60
105049 Covalent Organic Framework (COF): A Drug and Carrier to Attenuate Retinal Ganglion Cells Death in an Acute Glaucoma Mouse Model
Zhang G
Polymers 2022; 14:
104691 Trends in the prevalence of vision impairment among the oldest-old Chinese population from 1998 to 2018
Shen Z
Journal of global health 2022; 12: 11006
104938 Genetic and clinical features of BEST1-associated retinopathy based on 59 Chinese families and database comparisons
Xiao X
Experimental Eye Research 2022; 223: 109217
104628 Five-year incidence of primary glaucoma and related risk factors - The Handan eye study
Wang J
Acta Ophthalmologica 2023; 101: e50-e60
105049 Covalent Organic Framework (COF): A Drug and Carrier to Attenuate Retinal Ganglion Cells Death in an Acute Glaucoma Mouse Model
Rong Y; Zhang Q
Polymers 2022; 14:
104938 Genetic and clinical features of BEST1-associated retinopathy based on 59 Chinese families and database comparisons
Li S
Experimental Eye Research 2022; 223: 109217
104628 Five-year incidence of primary glaucoma and related risk factors - The Handan eye study
Li SZ
Acta Ophthalmologica 2023; 101: e50-e60
104691 Trends in the prevalence of vision impairment among the oldest-old Chinese population from 1998 to 2018
Chen Y; Wang K
Journal of global health 2022; 12: 11006
105049 Covalent Organic Framework (COF): A Drug and Carrier to Attenuate Retinal Ganglion Cells Death in an Acute Glaucoma Mouse Model
Liao Q
Polymers 2022; 14:
104938 Genetic and clinical features of BEST1-associated retinopathy based on 59 Chinese families and database comparisons
Sun W
Experimental Eye Research 2022; 223: 109217
104628 Five-year incidence of primary glaucoma and related risk factors - The Handan eye study
Thomas R; Wang NL
Acta Ophthalmologica 2023; 101: e50-e60
105049 Covalent Organic Framework (COF): A Drug and Carrier to Attenuate Retinal Ganglion Cells Death in an Acute Glaucoma Mouse Model
Zhang H
Polymers 2022; 14:
104938 Genetic and clinical features of BEST1-associated retinopathy based on 59 Chinese families and database comparisons
Wang P
Experimental Eye Research 2022; 223: 109217
104691 Trends in the prevalence of vision impairment among the oldest-old Chinese population from 1998 to 2018
Huang Z; De Fries CM
Journal of global health 2022; 12: 11006
104628 Five-year incidence of primary glaucoma and related risk factors - The Handan eye study
Acta Ophthalmologica 2023; 101: e50-e60
105049 Covalent Organic Framework (COF): A Drug and Carrier to Attenuate Retinal Ganglion Cells Death in an Acute Glaucoma Mouse Model
Xi K
Polymers 2022; 14:
